ION Exchange (India) Limited (IONEXCHANG)
Please find enclosed the Earnings Presentation for the first quarter ended June 30, 2026
Investor Presentation - Q1FY27
- Consolidated operating income 7,005mn +20.1% y-y; PAT 31mn -93.6% y-y
- Treatment Solutions revenue +14%; margins impacted by legacy projects; GCC dispatches resumed
- Industrial Products revenue +14%; EBIT margin improved to 11.89%; manufacturing expansion planned
- Lifecycle Services revenue +28%; EBIT margin down to 9.92% due to input costs; focus on O&M
- Specialty Chemicals revenue +21%; EBIT margin down due to geopolitical impact and Roha capex
- Consumer Products revenue +33%; EBIT margin slightly improved; growth in softener and wellness
- Strong orderbook 24,730mn; bid pipeline 97,770mn; overseas growth and new segments key drivers
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 IONEXCHANG — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add IONEXCHANG to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on ION Exchange (India) Limited
Important.
The summary above is generated automatically from ION Exchange (India) Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.